Laserfiche WebLink
rl poWence OT nosocomiai intections for <br />curveillance purposes. <br />2. Establish a practical system for reporting, early uniform identification, evaluations and <br />follow-up of infections among residents and personnel. <br />3. Establish an on-going review and evaluation of all aseptic, isolation, and disinfection <br />techniques. <br />4. Provide written infection control policies defining the infection control plan including <br />specific indications for isolation, and disinfection techniques. <br />5. Develop and implement policies in relation to the scope of employee health. <br />6. Orient all new employees regarding infection control and their responsibilities to the <br />plan as well as providing continuous in service to all departments concerning current <br />infection control recommendations / practices. <br />7. The plan I poli * cies and procedures shall be reviewed at least annually by the ICN and <br />Infection Control Committee. <br />The infection control policies and procedures shall be available at each nursi <br />station. i <br />jEREVENTION I PRACTICE <br />I . Residents: Residents will have an initial -step TB skin test (TST) unless positive <br />TB skin test or length of stay less than 5 days. If the resident has a history of positive <br />TB skin tests, a chest x-ray shall be required upon admission- Annual TB screening <br />shall be required for all residents. Other preventative measures include: annual flu <br />immunization, PneumovaG vaccine every 5 years, healthy nutritious meals and <br />• <br />adequate hydration. Documentation of Pneumovac immunizations shall be readily <br />accessible during an OBRA survey for completion of the HCFA 672 form. <br />2. Employees: New employees will have an inal -step TB skin test. Employees <br />having direct resident contact will be skin tested annually if last TST was negative. <br />Employees with positive TB skin test shall receive an initial chest x-ray and an annua <br />follow-up questionnaire. If the employee has received prophylactic treatment for TB <br />has a positive TB skin test, the employee will be interviewed annually for signs and <br />pto <br />symms of TB. Ap <br />ny employee with symptoms of TB shall be referred for follow u <br />investigation and treatment as indicated. I <br />M117 MOP 7 =Fj. - V=41TTMWTW5e •'I, -r <br />the Hepatitis B vaccine. Declination will be documented. <br />Employees shall be offered or encouraged to have annual influenza vaccine- <br />tn%cfim <br />